Microfluidic Cell Culture Device With Structured Surface Projections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell culture methods using flat surfaces fail to replicate the three-dimensional in vivo environment, leading to diminished relevance of drug testing results, as cells in the human body experience complex three-dimensional environments that are not adequately mimicked by conventional two-dimensional cultures.
Innovation Solution
Microfluidic devices with structured surfaces and multiple perfusion channels that suspend cells above the surface, mimicking tissue architecture and flow conditions, allowing for the formation of tissue-like structures and restoration of membrane polarity without biological or synthetic matrices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If cells are cultured on flat surfaces, then cell culture is simple and easy to manufacture, but cells form artificial two-dimensional sheets that do not mimic in vivo conditions
Solution Approach 1:
The patent transitions from two-dimensional flat surfaces to three-dimensional microfluidic channels with varying heights. The channel depth is specifically designed to be less than the cell diameter, forcing cells to adopt three-dimensional morphology while maintaining ease of manufacture through standard microfluidic fabrication techniques.
Solution Approach 2:
The microfluidic channels are designed with non-uniform depth characteristics, where different regions of the channel have different depths. This creates local variations in cell morphology and orientation, allowing cells to exhibit diverse three-dimensional structures that better mimic in vivo tissue architecture while maintaining manufacturability.
2Device complexity
If cells are cultured on flat surfaces, then the device structure is simple, but cell function and relevance to in vivo conditions are diminished
Solution Approach 1:
The patent introduces vertical dimensionality through microfluidic channels with depths less than cell diameter, enabling cells to form three-dimensional structures that maintain in vivo-like functionality. This dimensional change is achieved through standard microfabrication processes, avoiding excessive device complexity while significantly improving cell functional relevance.
Solution Approach 2:
The patent utilizes fluid flow dynamics within the microfluidic channels to control cell positioning, orientation, and morphology. By adjusting flow rates and channel dimensions, the system maintains cell function and in vivo relevance without requiring complex mechanical or structural components.
3Shape
If three-dimensional cell structures are implemented, then in vivo-like morphology is achieved, but device complexity increases
Solution Approach 1:
The patent achieves three-dimensional cell morphology by designing microfluidic channels with depths less than cell diameter, forcing cells to adopt vertical structures. This approach maintains relative device simplicity by using straightforward channel geometries rather than complex multi-component systems.
Solution Approach 2:
The microfluidic channel structure serves multiple functions simultaneously: it provides three-dimensional cell support, enables controlled fluid perfusion, facilitates waste removal, and maintains cell morphology. This multi-functionality reduces the need for additional separate components, thereby limiting device complexity while achieving in vivo-like cell structures.
4Ease of manufacture
If conventional two-dimensional cell culture is used, then manufacturing is easy, but drug testing results lack relevance to in vivo responses
Solution Approach 1:
The patent transitions from two-dimensional to three-dimensional cell culture using microfluidic channels with depths less than cell diameter. This dimensional change enables cells to maintain in vivo-like morphology and function, thereby improving drug testing relevance while keeping manufacturing relatively simple through standard microfabrication techniques.
Solution Approach 2:
The patent employs controlled fluid flow through the microfluidic channels to provide dynamic culture conditions that mimic in vivo perfusion. This hydraulic approach enables better nutrient delivery and waste removal, improving cell functionality and drug testing relevance without requiring complex mechanical systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These devices promote long-term, in vivo-like cellular organization and functionality, enabling sustainable dynamic conditions for cell culture, including controlled oxygen and nutrient supply, and efficient waste removal, thereby enhancing the relevance of in vitro drug testing and toxicity studies.
Implementation Method 1
a perfusion channel through which cell culture medium or other fluid compositions may be flowed
Implementation Method 2
The structured surfaces include projections configured to suspend cells above the bottom of the structured surface
Implementation Method 3
controlled oxygen and nutrient supply, and efficient waste removal
Data Source
AI summary
A microfluidic cell culture apparatus includes a cell retention chamber and a perfusion channel. The cell retention chamber has a structured surface. The structured surface includes a major surface from which a plurality of projections extends into the chamber. The plurality of projections are arranged to suspend cells cultured in the chamber above the major surface. The first perfusion channel is configured to provide laminar flow of a fluid through the channel and forms a plurality of openings in communication with the cell retention chamber. The openings are configured to prevent cells from the retention chamber from entering the perfusion channel.